Skip to main content
. 2023 Mar 9;61(3):2201193. doi: 10.1183/13993003.01193-2022

FIGURE 4.

FIGURE 4

Effect of ecleralimab on fractional exhaled nitric oxide (FENO) change from baseline compared with placebo over 85 days. A blue circle around the study day indicates allergen inhalation challenge (AIC) and a box indicates an allergen challenge triad. Data are presented as mean±se. *: p<0.05 significant difference in change from baseline in ecleralimab versus change from baseline in placebo.